|
SLC19A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.439500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.428300E-04 |
| Normal-vs-Stage2 |
1.577040E-03 |
| Normal-vs-Stage3 |
8.559800E-01 |
| Normal-vs-Stage4 |
1.773520E-04 |
| Stage1-vs-Stage2 |
9.906000E-01 |
| Stage1-vs-Stage3 |
2.835400E-01 |
| Stage1-vs-Stage4 |
7.774500E-02 |
| Stage2-vs-Stage3 |
2.822800E-01 |
| Stage2-vs-Stage4 |
8.245600E-02 |
| Stage3-vs-Stage4 |
8.121900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.615600E-04 |
| Normal-vs-AfricanAmerican |
1.536440E-02 |
| Normal-vs-Asian |
2.065900E-02 |
| Caucasian-vs-AfricanAmerican |
8.703000E-01 |
| Caucasian-vs-Asian |
7.751000E-01 |
| AfricanAmerican-vs-Asian |
5.207000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.388400E-04 |
| Normal-vs-Female |
2.494500E-02 |
| Male-vs-Female |
4.264400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.468800E-01 |
| Normal-vs-Extreme_Weight |
1.756780E-04 |
| Normal-vs-Obese |
4.335900E-02 |
| Normal-vs-Extreme_Obese |
7.584400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.971360E-01 |
| Normal_Weight-vs-Obese |
5.578000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.463600E-01 |
| Extreme_Weight-vs-Obese |
3.389600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.642200E-02 |
| Obese-vs-Extreme_Obese |
4.920800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.708200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.361000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.750400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.836400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.106600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.186200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.825390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.409800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.257950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.468400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85700010923995E-10 |
| Normal-VS-Type2 PRCC |
3.916400E-01 |
| Normal-VS-KIRP CIMP |
1.072270E-02 |
| Normal-VS-Unclassified PRCC |
4.698200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.233900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.853200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.923610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.979420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.427800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.514600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.183030E-01 |
| Normal-vs-N1 |
2.624600E-01 |
| Normal-vs-N2 |
2.322200E-02 |
| N0-vs-N1 |
9.091200E-01 |
| N0-vs-N2 |
6.308400E-01 |
| N1-vs-N2 |
7.167000E-01 |
|
|
